(Q46374470)

21 December 2017

title

Differential toxicity of anthracyclines on cultured endothelial cells (English)

1 reference

21 December 2017

0 references

Varsha Kaushal

1

1 reference

21 December 2017

G P Kaushal

series ordinal

2

1 reference

21 December 2017

Paulette Mehta

series ordinal

3

1 reference

21 December 2017

publication date

1 September 2004

1 reference

21 December 2017

Endothelium: Journal of Endothelial Cell Research

published in

1 reference

21 December 2017

volume

11

1 reference

21 December 2017

issue

5-6

1 reference

21 December 2017

page(s)

253-258

1 reference

21 December 2017

The Bcl-2 protein family: arbiters of cell survival

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Cellular survival: a play in three Akts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Recent advances in the prevention of anthracycline cardiotoxicity in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Anthracyclines in haematology: pharmacokinetics and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Anthracycline cardiotoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

The cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Cardiac safety of liposomal anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Vascular actions of anthracycline antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

Cardiac toxicity of antineoplastic anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320490904124

10.1080/10623320490904124

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017